Patent · US Active

Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye

US8227452B2 · kind B2 · utility

1Cited by

0References

9Claims

0Family size

Assignee

Novagali Pharma SA · FR

Inventors

Laura Rabinovich-Guilatt · Even Yehuda, IL
Gregory Lambert · Rouen, FR

Key dates

Filing date	Jun 1, 2007
Grant date	Jul 24, 2012
Priority date	—
Expiry date	Mar 3, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Use of a composition comprising at least one prodrug of a steroid, preferably of a corticosteroid, for the preparation of an ophthalmic composition intended for the treatment of an ocular condition or disease of a human being or an animal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.